Abstract
SQUID-based magnetoencephalography has been shown to improve the diagnosis and surgical treatment decision for presurgical evaluation of drug-resistant epilepsy. Still, its use remains limited due to several constraints such as cost, fixed helmet size and obligation of immobility. A new generation of sensors, the optically pumped magnetometers (OPMs), could overcome these limitations. In this study, we validate the ability of innovative Helium-based OPM (4He-OPM) sensors to record epileptic brain activity thanks to simultaneous recordings with intracerebral EEG (stereotactic EEG, SEEG). We recorded simultaneous SQUIDs-SEEG and 4He-OPM-SEEG signals in one patient during two sessions. We show that epileptic activities on intracerebral EEG can be recorded by OPMs with a better signal-to noise ratio than classical SQUIDs. The OPM sensors open new venues for the widespread application of magnetoencephalography in the management of epilepsy and other neurological diseases and fundamental neuroscience.
Significance Statement We performed a simultaneous recording of Helium-based Optically Pumped Magnetometers (OPM) and intracerebral EEG and validate for the first time OPM results with signals recorded directly within the brain. We demonstrate that epileptic abnormalities seen on intracerebral electrodes are detected by OPMs with a better signal-to noise ratio than classical magnetoencephalography. This represents a significant step towards the validation of OPM-based recordings for epilepsy diagnosis and for clinical and neuroscience research.
Competing Interest Statement
EL, APL, ML, holds founding equity in Mag4Health, a CEA-LETI spin off company whose aim is to commercialize Helium OPM based MEG systems. The remaining authors have no conflicts of interest.
Funding Statement
This study was funded by AP-HM and CEA-LETI
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval was obtained at the AssistancePublique - Hopitaux de Marseille (AP-HM) under IDRCB 2020-A01830-39 and the patient gave informed written consent
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
